Xtacy Therapeutics (XCNQ:XTCY) 3-Year EBITDA Growth Rate : 21.30% (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Xtacy Therapeutics 3-Year EBITDA Growth Rate?

Xtacy Therapeutics's EBITDA per Share for the three months ended in Jun. 2024 was C$-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 21.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 38.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Xtacy Therapeutics was 79.90% per year. The lowest was -121.80% per year. And the median was 21.30% per year.

Competitive Comparison of Xtacy Therapeutics's 3-Year EBITDA Growth Rate

For the Credit Services subindustry, Xtacy Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xtacy Therapeutics's 3-Year EBITDA Growth Rate Distribution in the Credit Services Industry

For the Credit Services industry and Financial Services sector, Xtacy Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Xtacy Therapeutics's 3-Year EBITDA Growth Rate falls into.

Xtacy Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Xtacy Therapeutics (XCNQ:XTCY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Xtacy Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Xtacy Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Xtacy Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Xtacy Therapeutics Corp (XCNQ:XTCY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

XTCYF:USA TT5:Germany

Address

1100 - 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://globalwellnessstrategies.com

Xtacy Therapeutics Corp Formerly Global Wellness Strategies Inc is a debt financing company. The company provides a debt financing facility to help companies build their valuation and get to the next level in its financing cycle without giving away equity prematurely in their growth cycle. It is focusing on providing finance to medical cannabis, hemp, and CBD-related, healthcare-related target companies.

Xtacy Therapeutics Headlines

No Headlines